253315-30-9 Usage
Description
5-(3-Trifluoromethylphenyl)-oxazole-4-carboxylic acid is a chemical compound with the formula C11H6F3NO3. It is a carboxylic acid derivative of oxazole, containing a trifluoromethylphenyl substituent at the 5-position. 5-(3-TRIFLUOROMETHYLPHENYL)-OXAZOLE-4-CARBOXYLIC ACID has potential applications in medicinal and agricultural chemistry due to its ability to act as a building block for the synthesis of biologically active molecules.
Uses
Used in Pharmaceutical Industry:
5-(3-TRIFLUOROMETHYLPHENYL)-OXAZOLE-4-CARBOXYLIC ACID is used as an intermediate in the production of pharmaceuticals for its potential to contribute to the synthesis of biologically active molecules.
Used in Agrochemical Industry:
5-(3-TRIFLUOROMETHYLPHENYL)-OXAZOLE-4-CARBOXYLIC ACID is used as an intermediate in the production of agrochemicals, enabling the creation of molecules with pesticidal or herbicidal properties.
Used in Specialty Chemicals Production:
5-(3-TRIFLUOROMETHYLPHENYL)-OXAZOLE-4-CARBOXYLIC ACID is used as a building block for the synthesis of specialty chemicals, given its unique structural characteristics and properties.
Used in Organic Chemistry Research and Development:
5-(3-TRIFLUOROMETHYLPHENYL)-OXAZOLE-4-CARBOXYLIC ACID is used as a target for further research and development in the field of organic chemistry, due to its interesting structural features and potential for creating new compounds with various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 253315-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,3,1 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 253315-30:
(8*2)+(7*5)+(6*3)+(5*3)+(4*1)+(3*5)+(2*3)+(1*0)=109
109 % 10 = 9
So 253315-30-9 is a valid CAS Registry Number.
253315-30-9Relevant articles and documents
AMINOTRIAZOLE DERIVATIVES AS ALX AGONISTS
-
Page/Page column 113, (2009/07/18)
The invention relates to aminotriazole derivatives of formula (I), wherein A, E, R1 and R2 are as defined in the description, their preparation and their use as pharmaceutically active compounds. The compounds are useful for the prevention or treatment of diseases, which respond to the modulation of the ALX receptor such as inflammatory diseases.